Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001739104-26-000043
FAQ
- What is Elanco Animal Health Inc.'s D&A?
- Elanco Animal Health Inc. (ELAN) reported D&A of $171M in Q2 2026.
- How has Elanco Animal Health Inc.'s D&A changed year-over-year?
- Elanco Animal Health Inc.'s D&A increased by 1.2% year-over-year, from $169M to $171M.
- What is the long-term trend for Elanco Animal Health Inc.'s D&A?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s D&A has grown at a -1.3% compound annual growth rate (CAGR), from $716M to $680M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Elanco Animal Health Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude